Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement
Pain at the injection site, fatigue, headache, myalgias, arthralgias, chills, and fever can be early indicators of an increased need for glucocorticoid replacement in patients with adrenal insufficiency. The Pituitary Society surveyed its membership to understand planned approaches to glucoc Corticoid management in patients who will receive a COVID-19 vaccine.
